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Background: To analyze and compare dose distribution homogeneity in selected points (espe-
cially in the chest wall region) for patients irradiated with two different TBI techniques to
achieve a uniform total dose (excluding lungs area) speciﬁed in the range of 11.4–14.0 Gy.
Material and methods: From August 2000 to December 2009, a group of 158 patients was treated
by  the use of 15 MV photon irradiation consisting of six fractions: four opposed lateral and
two anterior–posterior/posterior–anterior (AP/PA). Patients were irradiated with the fraction
dose of 2 Gy twice a day for 3 consecutive days. The prescribed dose to PC point (speciﬁed
at  intersection of the beam axis with the mid-plane of the patient irradiated laterally) was
12  Gy. Since January 2010 until closing the study, another group of 50 patients was  treated
according to a modiﬁed protocol. The treatment was carried out in six lateral fractions only,
twice a day, for three following days and a lateral lung shield was used for a part of total
irradiation time. The measurements of doses in 20 selected points of patient’s body were
carried out by means of MOSFET detectors.
Results: The modiﬁed TBI technique allows to achieve an expected homogenous dose in the
points of interest similar to that obtained by using the initial protocol. The calculated andmeasured in vivo doses met the speciﬁed range of 11.4–14 Gy for both applied TBI protocols.
Conclusions: Our results indicate that for all patients the homogenous dose distribution in
the  speciﬁed range was achieved.
©  2012 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z o.o. All
chemotherapy as a conditioning regimen for BMT  or periph-. Backgroundor many  years the total body irradiation (TBI) technique was
 part of conditioning prior to Bone Marrow Transplantation
BMT) in hematological malignancies. This kind of therapy has
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been recognized as one of the most important treatments for
hematological malignancies. It is used in conjunction witheral blood stem cell transplantation.1–3 The main purpose of
the irradiation is to suppress the patient’s immune system and
prevent bone marrow rejection from unrelated donors. TBI is
ed by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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also a tool to eradicate abnormal cells which survived other
therapies, such as surgery, chemotherapy or local irradiation,
and which are hidden in the patient’s body with potential to
grow again.
TBI is generally delivered twice a day for two to ﬁve con-
secutive days. A number of techniques have been developed
in different centers, and the choice of a technique depends
on conditions available in a particular center.4–13 Methods
of TBI are the following: parallel-opposed lateral ﬁeld’s tech-
nique, parallel-opposed anterior–posterior/posterior–anterior
(AP/PA) technique or a composition of lateral and AP/PA ﬁelds,
divided into 4–10 fractions. Such a schedule allows normal tis-
sues to repair radiation damage. The TBI technique usually
yields in a very irregular extended ﬁeld, therefore it is essential
to achieve a homogenous radiation dose over the whole body.
Such a task requires a very careful setup to minimize possi-
ble errors (recommended AAMP error range for TBI is −10% to
+5%).14,15
In such an extended area, doses delivered in some points
can be higher than those prescribed to a PC point by up to
even ± 15%.14 We  can conﬁrm previously reported results of
other centers14–17 that it is not easy to maintain narrow per-
centage deviation from planned dose.
The main goal in TBI is to maintain, as well as possible, dose
uniformity over a large area of patient’s body and keep critical
organs, usually lungs, and in some reasonable cases kidneys
or eyes, at the lowest possible level of doses.16,18–24 Radia-
tion oncologists determine the criteria of irradiation doses for
organs at risk.
In the recent years, signiﬁcant technological progress can
be observed in the ﬁeld of radiotherapy. It results in high qual-
ity of patients treatment, in which the most important factors
are the accuracy of beam delivery and improved patient’s com-
fort during irradiation. The last issue is directly related to
the period of time that the patient spends on a treatment
table in a therapy room. Both quality improvement factors
can be assured by such techniques like Intensity-Modulated
Radiation Therapy (IMRT), Image  Guided Radiation Therapy
(IGRT), Volumetric Modulated Arc Therapy (VMAT), Tomother-
apy, etc.25 Some new technological approaches have also been
investigated and applied for TBI and Total Marrow Irradia-
tion (TMI) therapies.18,26–29 Over the last ten years, the TBI
technique administered in our department has also been
modiﬁed.
Fig. 1 – POLKAM TBI – total body tableiotherapy 1 7 ( 2 0 1 2 ) 367–375
2.  Aim
The target of this report is to present two ways of admin-
istering total body irradiation, as well as to analyze results
and compare dose distribution homogeneity in 20 selected
anatomical points (especially in the chest wall region) for
patients irradiated with two modes of the TBI technique. The
goal was to achieve the most uniform total dose (excluding
lungs area) in the range of 11.4–14.0 Gy (i.e. 95–116% of 12 Gy
prescribed to reference point PC-speciﬁed at the intersection
of the beam axis with the mid-plane of the patient irradiated
laterally). The percentage range is a result of dosimetrical con-
ditions of our therapeutic devices (like measured dose proﬁles
and PDD) and it is considered by radiation oncologists to be
acceptable and safe for patients.
3.  Materials  and  methods
The results of dose measurements and analyses of dose distri-
bution were carried out for a group of 208 irradiated patients.
4.  POLKAM  table
POLKAM TBI Treatment Table is applied for reproducibility of
patient positioning and ﬁxation during irradiation of patient. It
is composed of two separate parts: Positioning Table and Ther-
apeutic Frame for patient immobilising during irradiation. In
general, Polkam TBI Treatment Table was designed in our
Department of Radiotherapy, manufactured by ZDAJ-HITEC
company in Otwock-S´wierk and awarded the 2008 “Teraz Pol-
ska” (“Now Poland”) distinguishing mark.
Therapeutic Frame consists of two plates made of plexiglas
sized 206 cm ×40 cm and 1 cm in thickness, placed parallel to
each other and ﬁxed together with a possibility to change the
distance between them. The built-up effect takes place in the
plexiglas plates, so that we can obtain a full prescribed dose to
the patient’s skin.30–32 Two rows of markers are placed on the
plates in a distance of 10 cm from each other to ﬁx the charac-
teristic points on the patient’s body. These points are mappedachieve the same patient’s positioning during each irradiation
course (Fig. 1).
 with special therapeutic frame.
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Table 1 – Distribution of cases treated in the years
2000–2009.
Diagnosis Number of cases
Leucemia limphoblastica acuta (ALL + CML) 109
Lymphoma malignum (NHL) 28
a
(
i
u
f
a
4
F
(
t
o
1
ﬁ
2
o
sLymphogranulomatosis malignum (LGM) 10
Plasmocytoma 11
Total 158
The therapeutic frame is equipped with an easily remov-
ble cover plate which protects knees during lateral irradiation
for maximum treatment ﬁeld size, adult patients should be
rradiated with bended knees). Therapeutic frame can also be
sed for patient positioning and immobilizing during AP/PA
ractions. In this case, the therapeutic frame is placed on the
ccelerator’s conventional treatment table.
.1.  Initial  mode  of  TBI  application
rom August 2000 to December 2009, a group of 158 patients
age ranging from 2 to 63 years – see Table 1) were treated using
he technique described in papers.33,34
The technique consisted of six fractions: four lateral
pposed (SSD = 330 cm,  ﬁeld 40 cm ×40 cm at the distance of
00 cm,  dose-rate 4.3 cGy/min) and two AP/PA (SSD = 135 cm
eld 40 cm ×40 cm at the distance of 100 cm,  dose-rate
3.6 cGy/min). Each AP/PA fraction consisted of four pairs of
pposing ﬁelds. Fields junction region (Fig. 2) was checked by
eparate measurements. Dose in the gap and overlap region
Fig. 2 – Illustration of AP/PA fractiotherapy 1 7 ( 2 0 1 2 ) 367–375 369
did not differ substantially from the assumed homogeneity.33
Photon beams of 15 MV were used.
The basic issue of dose distribution over the whole patient’s
body is the variation of their shape from head to feet. To
improve the uniformity of dose distribution, the empty vol-
ume  between the patient and the therapeutic frame walls was
ﬁlled with bags of rice, constituting a bolus (Fig. 3). Patients
were irradiated with fraction dose of 2 Gy, twice a day for
three consecutive days. During the AP/PA and lateral fraction,
Wood’s alloy shields were used for lungs to maintain the total
dose in lungs region below 9 Gy. Shield and patient positioning
veriﬁcation was checked before the ﬁrst lateral fraction with a
shield X-ray ﬁlm and before AP/PA fraction with the use of an
electronic portal ﬁlm. The shape of each shield was traced on
patient’s skin for AP/PA fractions, and on the frame plexiglas
wall for lateral fractions (see Fig. 3), after checking the shield
location correctness. Markers on the patient’s skin and these
on the frame walls are helpful to achieve a proper location
in subsequent fractions. These drawings can be used in the
next shielded fraction, without having to do another portal or
X-ray ﬁlm. Electron boosts for the chest wall were delivered
with lead electron apertures. The shape of these ﬁelds was an
aperture of photon AP/PA shields.
4.2.  Modiﬁed  mode  of  TBI  applicationSeveral improvements in our Radiotherapy Department equip-
ment, which took place in 2009, resulted in the modiﬁcation
of the TBI irradiation technique, because our accelerators had
ns and ﬁelds junction region.
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Fig. 3 – Rice bags as a
Table 2 – Distribution of cases treated with modiﬁed TBI
technique.
Diagnosis Number of cases
Leucemia limphoblastica acuta (ALL + CML) 26
Lymphoma malignum (NHL) 21
Lymphogranulomatosis malignum (LGM) 3
Total 50
been furnished with additional devices, like portal and orto-
voltage imaging, improving standard techniques. Therefore,
practical application of TBI required to adapt the method to
technical possibilities of accelerators. Changes in the acceler-
ator equipment made the AP/PA fractions more  complicated
to realize in such geometric conditions. Since January 2010,
our patients have been treated with a modiﬁed technique,
which is easier and less time consuming. Fifty patients
(aged 5–60) have already been irradiated according to the
modiﬁed schedule with the prescribed dose of 12 Gy to PC
point (Table 2).
According to the modiﬁed protocol, treatment was car-
ried out with 15 MV  photon beam in six lateral fractions only
(SSD = 330 cm ﬁeld 40 cm × 40 cm at the distance of 100 cm,
Fig. 4 – Localization of points for which th bolus material.
dose-rate 6.5 cGy/min), two fractions a day for three con-
secutive days. For the use of this technique, the radiation
oncologists decided to deliver the dose to the mediastinum
and lungs area equal to 10 Gy which is essential for therapy.
Therefore, a lateral lung shield was used for a part time of
the total irradiation. In certain reasonable cases, the radia-
tion oncologists decided not to use the lung shields and then
the lungs and mediastinum region were irradiated with full
dose of 12 Gy. Reports can be found in available literature20
where doses of 10 Gy or even 11 Gy were delivered to the
lung tissue, and well tolerated with no complications after
radiotherapy. The time of lungs shielding to decrease the
dose to 10 Gy is calculated, and closely depends on an indi-
vidual patient’s anatomy. Correctness of an individual shield
positioning before the ﬁrst fraction was checked by an X-ray
ﬁlm. After checking the shield location correctness, the shield
shape was traced on the frame plexiglas wall (see Fig. 3), and it
could be used for the next shielded fractions. The underdosage
in the lateral chest wall region was supplemented to the dose
of 12 Gy by electron beams of the nominal energy from 6 MeV
to 12 MeV. The shape of an electron irradiation ﬁeld is an aper-
ture of photon shield and is mapped from treatment planning
system (TPS).
e doses are calculated and measured.
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pFig. 5 – Metal-oxide semiconductor ﬁ
.3.  Dose  distribution  veriﬁcation
o investigate the homogeneity of dose distribution in the
ntire body of the patient, 20 measurement points were des-
gnated (Fig. 4) and for these points the doses were calculated
nd then measured. The prescribed dose to PC point was 12 Gy.
Dose veriﬁcation measurements were performed by the
se of miniature Metal-Oxide Semiconductor Field Effect Tran-
istor (MOSFET) detectors (see Fig. 5) with detector active
olume less than 1 mm3. Parameters of these detectors have
een described in papers.35,36 Their measurements accuracy
s 2.2% (1SD).
On introduction of this method, the Farmer type 0.6cc ion-
zation chamber was used for a double check of the dose in PC
oint. Since the difference between both readings (MOSFET
nd Farmer) was negligible (less than 2%), the double check
as abandoned and MOSFET established as a chosen tech-
ique for TBI in vivo dosimetry.
Additionally, the problem of very small dimensions ofOSFETS detectors requires special solution for electron
elds applied as the boost for the chest wall. To ensure
lectron equilibrium within the area of measurement, the
ig. 6 – The values of percent difference between the measured a
atient treated with the initial TBI technique.effect transistor (MOSFET) detectors.
detectors were placed in specially designed aluminium
capsules.36
5.  Results  and  discussion
The percent difference between measured and calculated dose
to PC point was determined at each of the 20 points for patients
in both groups. The results are presented in Figs. 6 and 7. It
can be observed that, taking into account all results, the mean
percent difference between the measured and planned dose to
PC point is 6.4% (SD = 4.7%) and 7.9% (SD = 6.4%) for the initial
TBI technique and the modiﬁed one, respectively.
The results presented in Table 3 show the mean percent-
age differences between measured dose in individual points,
taking into account all patients in a particular group.
The modiﬁed TBI technique allows to achieve the expected
homogenous dose in the points of interest similar to thoseand measured doses in most cases met  the range of 11.4–14 Gy
(95–116% of the dose of 12 Gy planned to PC point), which was
a required result (see Fig. 7).
nd planned dose to PC = 12 Gy for all anatomical point of
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Fig. 7 – The values of percent difference between the measured and planned dose to PC = 12 Gy for all anatomical point of
patient treated with the modiﬁed TBI technique.
The distribution of doses for all patients and for all points
presented on the graphs (Figs. 6 and 7) and in Table 3 is in most
cases contained within the range from −5% to 16% for both
analyzed groups of patients. The greatest inhomogeneity of
dose distribution appears in the chest area. It is caused by the
tissue diversity and the shielding used in this area. However,
our intention was to reduce the dose in the lungs.
Fig. 8 shows a graphical representation of dose distribution
in the chest area for the case of using the initial TBI technique
with the AP/PA ﬁelds, lateral ﬁelds and electron boosts for the
chest wall.
The same case with a graphical representation of dose
distribution in the chest area planned for the modiﬁed TBI
Table 3 – Percentage difference between the measured and plan
Point number N = 158 patients 
%SD %Mean
1 5.2 8.8 
1a 5.3 8.2 
2 4.2 5.6 
2a 4.5 5.4 
3 4.4 2.6 
3a 3.8 2.9 
4 4.0 7.4 
4a 4.0 2.7 
5 4.8 6.0 
5a 5.3 5.9 
6 5.3 7.8 
6a 5.8 7.9 
7 5.7 7.4 
7a 4.3 8.9 
8 3.4 6.3 
8a 4.1 6.4 
9 3.3 5.3 
9a 4.1 8.4 
10 2.1 4.4 
10a 1.7 4.9 
Total 4.3 6.4 technique is shown in Fig. 9. In this case, the TBI irradiation
technique consisted only of lateral ﬁelds and lateral electron
boosts for the chest wall. It can be seen that in comparison
with the initial TBI protocol, the dose in the mediastinum is
lower while the dose in lungs is slightly higher.
Therefore, we are considering to use the technique of
dynamic photon irradiation in the chest area which allows to
increase the dose to the mediastinum while sparing lung tis-
sue. For this purpose, patient should be exposed to a lateral
radiation in six fractions, like so far, and their whole chest
region shielded with a block. Then the dose will be delivered
as a VMAT plan in 2 or 3 fractions. Fig. 10 shows a graphical
simulation of dose distribution in the chest area, prepared in
ned dose to PC for individual points.
N = 50 patients
 diff. %SD %Mean diff.
3.1 13.7
3.1 14.4
4.6 9.2
4.7 9.1
4.0 0.2
3.7 2.5
4.3 9.3
4.7 9.3
4.5 9.2
4.7 8.9
5.4 10.7
5.1 10.5
5.3 10.6
5.2 2.5
5.1 11.0
6.2 11.0
4.2 2.1
2.9 0.6
4.7 7.9
4.8 8.7
4.5 7.9
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Fig. 8 – Dose distribution in chest region – a sum of two AP/PA fractions with electron boosts and four lateral fractions –
planned dose to PC was 12 Gy.
Fig. 9 – Dose distribution in chest region – 6 lateral fraction with lateral electron boost.
Fig. 10 – VMAT  as an advanced solution for dose distribution in chest with mediastinum region.
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the Monaco treatment planning system as a dynamic VMAT
plan.
6. Conclusions
In conclusion, it can be pointed out that in general (except
few points) differences between the planned and measured
doses in relation to PC point are contained between −5% to
+16% (excluding the chest area). Both presented TBI tech-
niques allow to achieve the assumed dose distribution.
On the basis of prepared simulations for the VMAT  tech-
nique, without electron boosts, we can state, that this solution
seems to be an advanced technique for our TBI method, espe-
cially for lungs area. However, further research of this solution
is required in our Radiotherapy Department.
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